SEYED EBRAHIM KASSAIAN to Coronary Artery Disease
This is a "connection" page, showing publications SEYED EBRAHIM KASSAIAN has written about Coronary Artery Disease.
Connection Strength
1.829
-
Biodegradable-Polymer Biolimus-Eluting Stents versus Durable-Polymer Everolimus-Eluting Stents at One-Year Follow-Up: A Registry-Based Cohort Study. Tex Heart Inst J. 2016 Apr; 43(2):126-30.
Score: 0.288
-
Staged carotid artery stenting and coronary artery bypass surgery versus isolated coronary artery bypass surgery in concomitant coronary and carotid disease. J Invasive Cardiol. 2013 Jan; 25(1):8-12.
Score: 0.230
-
Glycosylated hemoglobin (HbA1c) levels and clinical outcomes in diabetic patients following coronary artery stenting. Cardiovasc Diabetol. 2012 Jul 17; 11:82.
Score: 0.223
-
Outcomes of stenting with overlapping drug-eluting stents versus overlapping drug-eluting and bare-metal stents for the treatment of diffuse coronary lesions. Cardiovasc J Afr. 2010 Nov-Dec; 21(6):311-5.
Score: 0.198
-
Effect of Age on Procedural Success, Complications, and Clinical Outcome From a Large Angioplasty Registry. Crit Pathw Cardiol. 2019 03; 18(1):23-31.
Score: 0.088
-
Novel Scoring System for Prediction of Cardiac Syndrome X in Women with Typical Angina and a Positive Exercise Tolerance Test. Tex Heart Inst J. 2018 02; 45(1):5-10.
Score: 0.082
-
Impact of Sex on Long-term Clinical Outcomes After Percutaneous Coronary Intervention. Crit Pathw Cardiol. 2017 12; 16(4):161-166.
Score: 0.081
-
Sex-dependent effects of diabetes mellitus on the revascularization rate in mid-term follow up of young patients with coronary artery disease. J Diabetes Complications. 2017 Dec; 31(12):1686-1690.
Score: 0.079
-
Predictors of major adverse cardiac events following elective stenting of large coronary arteries. Indian Heart J. 2018 Jan - Feb; 70(1):20-23.
Score: 0.078
-
Factors Associated with Anxiety in Premature Coronary Artery Disease Patients: THC-PAC Study. Acta Med Iran. 2016 Apr; 54(4):261-9.
Score: 0.072
-
Comparing clinical outcomes for a twelve-month trial of zotarolimus- and everolimus-eluting stents in patients with coronary artery disease: data from the THCRIC registry. Ther Adv Cardiovasc Dis. 2016 Aug; 10(4):206-13.
Score: 0.071
-
Selective versus exclusive use of drug-eluting stents in treating multivessel coronary artery disease: a real-world cohort study. Tex Heart Inst J. 2014 Oct; 41(5):477-83.
Score: 0.065
-
On-label and off-label use of drug-eluting stents: comparison of short- and long-term outcomes. Tex Heart Inst J. 2012; 39(1):24-9.
Score: 0.054
-
Sodium bicarbonate in preventing contrast nephropathy in patients at risk for volume overload: a randomized controlled trial. J Nephrol. 2010 Mar-Apr; 23(2):216-23.
Score: 0.047
-
In-hospital and mid-term clinical outcomes after percutaneous coronary intervention with the use of sirolimus- or paclitaxel-eluting stents. Kardiol Pol. 2009 Dec; 67(12):1344-50.
Score: 0.046
-
The association between coronary arterial dominancy and extent of coronary artery disease in angiography and paraclinical studies. Clin Anat. 2008 Sep; 21(6):519-23.
Score: 0.043
-
Clinical outcomes of drug-eluting stents compared with bare metal stents in our routine clinical practice. Hellenic J Cardiol. 2008 May-Jun; 49(3):132-8.
Score: 0.042
-
Short- and long-term outcomes of percutaneous coronary intervention in patients with low, intermediate and high ejection fraction. Cardiovasc J Afr. 2008 Jan-Feb; 19(1):17-21.
Score: 0.041